PRS-343 in HER2-Positive Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

University of Pittsburgh Medical Center (UPMC), Pittsburgh

Georgetown University, Lombardi Comprehensive Cancer Center, Washington D.C.

Johns Hopkins University School of Medicine, Baltimore

Sarah Cannon Research Institute, Nashville

M.D. Anderson Cancer Center, Houston

NEXT Oncology, San Antonio

START - South Texas Accelerated Research Therapeutics, LLC, San Antonio

University of Arizona Cancer Center, Tucson

University of California Los Angeles (UCLA), Santa Monica